Literature DB >> 25117069

TGF-β1 mediates estrogen receptor-induced epithelial-to-mesenchymal transition in some tumor lines.

Dong-Mei Fan1, Peng-Wei Qi, She-Gan Gao, Ya-Wei Chen, Xiao-Lin Cheng.   

Abstract

More and more studies have reported that epithelial-mesenchymal transition (EMT) involved in the process of cancer development and progression occurs. The EMT also plays an important role in the movement and transfer of the tumors. Transforming growth factor-β (TGF-β) could induce the EMT in some cancer cell types. However, the mechanism underlying this transition process has also not been entirely clarified. In this study, the results indicated that TGF-β1-mediated EMT in the tumor was associated with the estrogen receptor (ER). The decreased expression of vimentin and snail resulted in the decrease of the ER expression by small interfering RNA-mediated silencing and preventing the TGF-β-induced EMT. In conclusion, our results indicated that TGF-β1 is an estrogen receptor signaling and essential novel downstream targets and could act as an important factor in the TGF-β-induced EMT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117069     DOI: 10.1007/s13277-014-2166-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.

Authors:  Sophia Sn Lam; Abby Sc Mak; Judy Wp Yam; Annie Ny Cheung; Hextan Ys Ngan; Alice St Wong
Journal:  Mol Ther       Date:  2014-01-14       Impact factor: 11.454

2.  Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.

Authors:  Mathilde Romagnoli; Karine Belguise; Ziyang Yu; Xiaobo Wang; Esther Landesman-Bollag; David C Seldin; Dany Chalbos; Sophie Barillé-Nion; Pascal Jézéquel; Margaret L Seldin; Gail E Sonenshein
Journal:  Cancer Res       Date:  2012-10-10       Impact factor: 12.701

3.  TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

Authors:  Michael K Asiedu; James N Ingle; Marshall D Behrens; Derek C Radisky; Keith L Knutson
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

Review 4.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

5.  Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.

Authors:  A E G Lenferink; C Cantin; A Nantel; E Wang; Y Durocher; M Banville; B Paul-Roc; A Marcil; M R Wilson; M D O'Connor-McCourt
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

6.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3.

Authors:  Damian Medici; Elizabeth D Hay; Bjorn R Olsen
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

7.  Astrocyte elevated gene-1 is a novel biomarker of epithelial-mesenchymal transition and progression of hepatocellular carcinoma in two China regions.

Authors:  Jiasheng Zheng; Cong Li; Xia Wu; Yingzhuo Yang; Meijun Hao; Shoupeng Sheng; Yu Sun; Honghai Zhang; Jiang Long; Caixia Hu
Journal:  Tumour Biol       Date:  2013-10-18

8.  Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.

Authors:  S M Farabaugh; D S Micalizzi; P Jedlicka; R Zhao; H L Ford
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

9.  LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.

Authors:  Hui-Wen Lue; Xiaojian Yang; Ruoxiang Wang; Weiping Qian; Roy Z H Xu; Robert Lyles; Adeboye O Osunkoya; Binhua P Zhou; Robert L Vessella; Majd Zayzafoon; Zhi-Ren Liu; Haiyen E Zhau; Leland W K Chung
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

10.  SOX4 mediates TGF-β-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition.

Authors:  Stephin J Vervoort; Ana Rita Lourenço; Ruben van Boxtel; Paul J Coffer
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

View more
  2 in total

1.  Mutational landscape implicates epithelial-mesenchymal transition gene TGF-β2 mutations for uterine carcinosarcoma after adjuvant tamoxifen therapy for breast carcinoma.

Authors:  Ling Shen; Liangli Hong; Songxia Zhou; Guohong Zhang; Ruiqin Mai
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.

Authors:  Zhan Shi; Xiang Li; Ding Wu; Run Tang; Renfu Chen; Song Xue; Xiaoqing Sun
Journal:  Tumour Biol       Date:  2015-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.